PURPOSE: We tested the hypothesis that (i) diet associated with exercise would improve arterial baroreflex (ABR) control in metabolic syndrome (MetS) patients with and without obstructive sleep apnea (OSA) and (ii) the effects of this intervention would be more pronounced in patients with OSA. METHODS:Forty-six MetS patients without (noOSA) and with OSA (apnea-hypopnea index, AHI > 15 events/h) were allocated to no treatment (control, C) or hypocaloric diet (- 500 kcal/day) associated with exercise (40 min, bicycle exercise, 3 times/week) for 4 months (treatment, T), resulting in four groups: noOSA-C (n = 10), OSA-C (n = 12), noOSA-T (n = 13), and OSA-T (n = 11). Muscle sympathetic nerve activity (MSNA), beat-to-beat BP, and spontaneous arterial baroreflex function of MSNA (ABRMSNA, gain and time delay) were assessed at study entry and end. RESULTS: No significant changes occurred in C groups. In contrast, treatment in both patients with and without OSA led to a significant decrease in weight (P < 0.05) and the number of MetS factors (P = 0.03). AHI declined only in the OSA-T group (31 ± 5 to 17 ± 4 events/h, P < 0.05). Systolic BP decreased in both treatment groups, and diastolic BP decreased significantly only in the noOSA-T group. Treatment decreased MSNA in both groups. Compared with baseline, ABRMSNA gain increased in both OSA-T (13 ± 1 vs. 24 ± 2 a.u./mmHg, P = 0.01) and noOSA-T (27 ± 3 vs. 37 ± 3 a.u./mmHg, P = 0.03) groups. The time delay of ABRMSNA was reduced only in the OSA-T group (4.1 ± 0.2 s vs. 2.8 ± 0.3 s, P = 0.04). CONCLUSIONS: Diet associated with exercise improves baroreflex control of sympathetic nerve activity and MetS components in patients with MetS regardless of OSA.
RCT Entities:
PURPOSE: We tested the hypothesis that (i) diet associated with exercise would improve arterial baroreflex (ABR) control in metabolic syndrome (MetS) patients with and without obstructive sleep apnea (OSA) and (ii) the effects of this intervention would be more pronounced in patients with OSA. METHODS: Forty-six MetS patients without (noOSA) and with OSA (apnea-hypopnea index, AHI > 15 events/h) were allocated to no treatment (control, C) or hypocaloric diet (- 500 kcal/day) associated with exercise (40 min, bicycle exercise, 3 times/week) for 4 months (treatment, T), resulting in four groups: noOSA-C (n = 10), OSA-C (n = 12), noOSA-T (n = 13), and OSA-T (n = 11). Muscle sympathetic nerve activity (MSNA), beat-to-beat BP, and spontaneous arterial baroreflex function of MSNA (ABRMSNA, gain and time delay) were assessed at study entry and end. RESULTS: No significant changes occurred in C groups. In contrast, treatment in both patients with and without OSA led to a significant decrease in weight (P < 0.05) and the number of MetS factors (P = 0.03). AHI declined only in the OSA-T group (31 ± 5 to 17 ± 4 events/h, P < 0.05). Systolic BP decreased in both treatment groups, and diastolic BP decreased significantly only in the noOSA-T group. Treatment decreased MSNA in both groups. Compared with baseline, ABRMSNA gain increased in both OSA-T (13 ± 1 vs. 24 ± 2 a.u./mmHg, P = 0.01) and noOSA-T (27 ± 3 vs. 37 ± 3 a.u./mmHg, P = 0.03) groups. The time delay of ABRMSNA was reduced only in the OSA-T group (4.1 ± 0.2 s vs. 2.8 ± 0.3 s, P = 0.04). CONCLUSIONS: Diet associated with exercise improves baroreflex control of sympathetic nerve activity and MetS components in patients with MetS regardless of OSA.
Authors: Daniel G Martinez; José C Nicolau; Rony L Lage; Edgar Toschi-Dias; Luciana D N J de Matos; Maria Janieire N N Alves; Ivani C Trombetta; Valdo J Dias da Silva; Holly R Middlekauff; Carlos E Negrão; Maria U P B Rondon Journal: Hypertension Date: 2011-10-24 Impact factor: 10.190
Authors: Krzysztof Narkiewicz; Philippe van de Borne; Nicola Montano; Dagmara Hering; Tomas Kara; Virend K Somers Journal: Hypertension Date: 2005-12-12 Impact factor: 10.190
Authors: Luciano F Drager; André R Brunoni; Raimundo Jenner; Geraldo Lorenzi-Filho; Isabela M Benseñor; Paulo A Lotufo Journal: Thorax Date: 2014-11-28 Impact factor: 9.139
Authors: M T La Rovere; G D Pinna; S H Hohnloser; F I Marcus; A Mortara; R Nohara; J T Bigger; A J Camm; P J Schwartz Journal: Circulation Date: 2001-04-24 Impact factor: 29.690
Authors: Maria T La Rovere; Roberto Maestri; Elena Robbi; Angelo Caporotondi; Gianpaolo Guazzotti; Oreste Febo; Gian D Pinna Journal: J Hypertens Date: 2011-08 Impact factor: 4.844
Authors: Luciano F Drager; Heno F Lopes; Cristiane Maki-Nunes; Ivani C Trombetta; Edgar Toschi-Dias; Maria Janieire N N Alves; Raffael F Fraga; Jonathan C Jun; Carlos E Negrão; Eduardo M Krieger; Vsevolod Y Polotsky; Geraldo Lorenzi-Filho Journal: PLoS One Date: 2010-08-11 Impact factor: 3.240
Authors: Luciano F Drager; Luiz A Bortolotto; Cristiane Maki-Nunes; Ivani C Trombetta; Maria Janieire N N Alves; Raffael F Fraga; Carlos E Negrão; Eduardo M Krieger; Geraldo Lorenzi-Filho Journal: Atherosclerosis Date: 2009-08-19 Impact factor: 5.162
Authors: Edgar Toschi-Dias; Ivani C Trombetta; Valdo J Dias da Silva; Cristiane Maki-Nunes; Felipe X Cepeda; Maria-Janieire N N Alves; Luciano F Drager; Geraldo Lorenzi-Filho; Carlos E Negrao; Maria Urbana P B Rondon Journal: Am J Physiol Heart Circ Physiol Date: 2013-01-25 Impact factor: 4.733
Authors: Satomi Shiota; Clodagh M Ryan; Kuo-Liang Chiu; Pimon Ruttanaumpawan; James Haight; Michael Arzt; John S Floras; Christopher Chan; T Douglas Bradley Journal: Thorax Date: 2007-04-18 Impact factor: 9.139
Authors: Claudia E Korcarz; James H Stein; Paul E Peppard; Terry B Young; Jodi H Barnet; F Javier Nieto Journal: Sleep Date: 2014-10-01 Impact factor: 5.849
Authors: Peter M Farrehi; Robert D Brook; Robert Godley; Patrick Walden; Qingmei Jiang; Melvyn Rubenfire Journal: J Clin Hypertens (Greenwich) Date: 2018-10-12 Impact factor: 3.738
Authors: Sofia K Konstantinidou; Georgia Argyrakopoulou; Nicholas Tentolouris; Vangelis Karalis; Alexander Kokkinos Journal: Exp Ther Med Date: 2021-11-23 Impact factor: 2.447